These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15453872)

  • 41. Advanced juvenile open-angle glaucoma in an 8-year-old Haitian girl.
    Sowka J
    Optometry; 2008 Mar; 79(3):126-32. PubMed ID: 18302954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diurnal variation of ocular pressure in open-angle glaucoma with telemonitoring].
    Antal S; Jürgens C; Grossjohann R; Tost FH
    Klin Monbl Augenheilkd; 2009 Mar; 226(3):168-75. PubMed ID: 19294587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of modified one-stage operation for cataract and glaucoma].
    Bakharev AV; Batmanov IuE
    Vestn Oftalmol; 2007; 123(4):6-9. PubMed ID: 17802752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Investigation of the biomechanical properties of the cornea in patients with normotensive and primary open-angle glaucoma].
    Avetisov SE; Bubnova IA; Antonov AA
    Vestn Oftalmol; 2008; 124(5):14-6. PubMed ID: 19062550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lifetime visual prognosis for patients with primary open-angle glaucoma.
    Ang GS; Eke T
    Eye (Lond); 2007 May; 21(5):604-8. PubMed ID: 16485015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in parapapillary atrophy between glaucomatous and normal eyes: the Beijing Eye Study.
    Xu L; Wang Y; Yang H; Jonas JB
    Am J Ophthalmol; 2007 Oct; 144(4):541-6. PubMed ID: 17651676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Luminance-modulated adaptation of global flash mfERG: fellow eye losses in asymmetric glaucoma.
    Chu PH; Chan HH; Brown B
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2626-33. PubMed ID: 17525193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study.
    Topouzis F; Coleman AL; Harris A; Koskosas A; Founti P; Gong G; Yu F; Anastasopoulos E; Pappas T; Wilson MR
    Am J Ophthalmol; 2008 Feb; 145(2):327-335. PubMed ID: 18045565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal glaucoma screening for siblings of patients with primary open angle glaucoma: the Nottingham Family Glaucoma Screening Study.
    Sung VC; Koppens JM; Vernon SA; Pawson P; Rubinstein M; King AJ; Tattersall CL
    Br J Ophthalmol; 2006 Jan; 90(1):59-63. PubMed ID: 16361669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma.
    Hirooka K; Baba T; Fujimura T; Shiraga F
    Am J Ophthalmol; 2006 Sep; 142(3):523-5. PubMed ID: 16935614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma population.
    Casas-Llera P; Rebolleda G; Muñoz-Negrete FJ; Arnalich-Montiel F; Pérez-López M; Fernández-Buenaga R
    Br J Ophthalmol; 2009 Dec; 93(12):1576-9. PubMed ID: 19535357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Minimal compression-load ophthalmoplethysmography in health and in primary open-angle glaucoma].
    Strakhov VV; Alekseev VV; Korchagin NV
    Vestn Oftalmol; 2009; 125(3):34-8. PubMed ID: 19566047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma.
    Pache M; Flammer J
    Surv Ophthalmol; 2006; 51(3):179-212. PubMed ID: 16644363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular features of the Hagberg-Santavuori syndrome.
    Bateman JB; Philippart M
    Am J Ophthalmol; 1986 Aug; 102(2):262-71. PubMed ID: 3017114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ghost cell glaucoma].
    Li ZH
    Zhonghua Yan Ke Za Zhi; 1984 Jan; 20(1):23-5. PubMed ID: 6434266
    [No Abstract]   [Full Text] [Related]  

  • 56. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [On the clinical picture of pigment glaucoma].
    LUDER P
    Ophthalmologica; 1961 Feb; 141():136-54. PubMed ID: 13764048
    [No Abstract]   [Full Text] [Related]  

  • 58. [The concept of the excessive scarring of the eye tissues after glaucoma-control operations].
    Lebedev OI
    Vestn Oftalmol; 1993; 109(1):36-9. PubMed ID: 8317086
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pigmentary glaucoma? Relations to megalocornea].
    Exnerová M; Kadlecová V; Peleska M
    Cesk Oftalmol; 1976 Jun; 32(3):169-77. PubMed ID: 949779
    [No Abstract]   [Full Text] [Related]  

  • 60. [Results of a 6-year observation of a case of ocular ochronosis coexisting with melanuria].
    Maciejasz A
    Klin Oczna; 1971; 41(3):439-41. PubMed ID: 5093455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.